A low plasma level of HDL cholesterol is an atherosclerotic risk factor; however, emerging
evidence suggests that low HDL levels might also contribute to the pathophysiology of type …

Insulin resistance often occurs with dyslipidemia as part of the metabolic syndrome and the
current dominant paradigm is that insulin resistance leads to dyslipidemia. However …

Background Despite the increasing prevalence of type 2 diabetes mellitus (T2DM), limited
pharmacologic options are available for prevention. Cholesteryl ester transfer protein …

Aims Insulin resistance (IR) changes over time during the development of type 2 diabetes.
Some reports showed that obesity was associated with progression of IR. However, no study …

Background Results of longitudinal researches regarding the temporal relationship between
dyslipidemia and insulin resistance (IR) are inconsistent. This study assessed temporal …

Dyslipidemias are known risk factors for chronic diseases. Precision nutrition interventions
are designed according to characteristics, such as diet, phenotype, and genotype. This …

Purpose Both type 2 diabetes (T2D) and low levels of high-density lipoprotein cholesterol
(HDL-C) are very prevalent conditions among Mexicans. Genetic variants in the LIPC gene …

Background and Aim Diabetic dyslipidaemia is common in type 2 diabetes (T2D) and insulin
resistance and often precedes the onset of T2D. The Taq1B polymorphism in CETP (B1 and …

Introduction: Cholesteryl ester transfer protein (CETP) is a key regulating enzyme in the lipid
metabolism pathway, and its gene polymorphism may be a candidate for modulating the …

This study aimed to investigate the relationship between the cholesterol ester transfer
protein (CETP) gene TaqIB polymorphism and the lipid-lowering effect of atorvastatin in …